Journal Report

Journal of Clinical Lipidology

Download PDF
Journal Information
Journal Title
Journal of Clinical Lipidology
Publisher
Elsevier Ltd
ISSN
1933-2874
E-ISSN
1876-4789
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Clinical and biochemical profile of c.703G>T p.(Glu235*): A novel pathogenic CYP27A1 variant of Cerebrotendinous Xanthomatosis
Ioannis Nikolakakis, Ioanna Koutroulou, Athina Ververi et al.
2026-11
DOI: 10.1016/j.jacl.2026.10.015
Dyslipidemia in Thin, Young, and “Triple-Negative” South Asians: Insights and a Wake Up Call from the ICMR-INDIAB
Prasad Gunasekaran, Vijay Nambi, Krishnaswami Vijayaraghavan
2026-11
DOI: 10.1016/j.jacl.2026.10.016
Potential for Cardiovascular Benefits of Resmetirom Based on LDL-Cholesterol and Lipoprotein(a) Lowering Consistent Across Statin Subgroups, a Secondary Analysis of the MAESTRO-NASH Phase 3 Clinical Trial
Meena B. Bansal, Rebecca Taub, Dominic Labriola et al.
2026-10
DOI: 10.1016/j.jacl.2026.10.004
Efficacy and diabetes risk of moderate-intensity statin plus ezetimibe versus high-intensity statin after percutaneous coronary intervention: A systematic review and meta-analysis
Francinny Alves Kelly, Luis Henrique Rios Moreira Rêgo, Thiago Gorayeb Rebelo et al.
2026-10 Vol. 20 Issue 10 Pages 2267-2276
DOI: 10.1016/j.jacl.2026.07.036
GPIHBP1 autoantibody positivity in patients with recurrent severe hypertriglyceridemia: frequency, phenotype, and derivation of an exploratory screening score
José Rioja, Daniel de la Cueva-Genovés, María José Ariza et al.
2026-10
DOI: 10.1016/j.jacl.2026.10.006
The addition of evolocumab vs ezetimibe to statin therapy for coronary plaque regression and sd-LDL reduction in patients with ultrahigh-risk ASCVD
Xiaoping Li, Lin Yang, Xiao Zhou et al.
2026-10 Vol. 20 Issue 10 Pages 2277-2287
DOI: 10.1016/j.jacl.2026.07.040
Fish oil supplementation reduces the CERT2 risk score in adults with increased cardiometabolic risk: Findings from the MoKaRi trial
Angelika Witoslawska, Christine Dawczynski, Mitja Lääperi et al.
2026-10 Vol. 20 Issue 10 Pages 2204-2213
DOI: 10.1016/j.jacl.2026.08.013
LDL-C management simplified: The National Lipid Association lipid simplified series
Eugenia Gianos, Nihar R. Desai, Kaye-Eileen Willard
2026-10
DOI: 10.1016/j.jacl.2026.09.020
Durable lipid-lowering beyond 10 years with lomitapide in homozygous familial hypercholesterolemia: A real-world experience in Taiwan
Chao-Feng Lin, Wen-Hwa Wang, Min-Ji Charng
2026-10 Vol. 20 Issue 10 Pages 2160-2171
DOI: 10.1016/j.jacl.2026.08.015
LDL-C, non–HDL-C, and ApoB: Complementary measures for better risk assessment
Sina Kianoush, Nathan D. Wong
2026-10
DOI: 10.1016/j.jacl.2026.10.010
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 5, 2026 14:57